Quantinno Capital Management LP Has $8.43 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

Quantinno Capital Management LP lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 11.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 28,089 shares of the company's stock after selling 3,661 shares during the quarter. Quantinno Capital Management LP's holdings in HCA Healthcare were worth $8,431,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Sanders Capital LLC increased its stake in shares of HCA Healthcare by 1.0% in the fourth quarter. Sanders Capital LLC now owns 11,655,563 shares of the company's stock valued at $3,498,417,000 after buying an additional 116,826 shares during the period. First Eagle Investment Management LLC grew its position in shares of HCA Healthcare by 0.5% during the 4th quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company's stock worth $1,351,830,000 after buying an additional 23,177 shares during the period. Geode Capital Management LLC lifted its holdings in shares of HCA Healthcare by 1.3% in the 4th quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company's stock worth $1,159,882,000 after purchasing an additional 50,321 shares in the last quarter. Capital World Investors lifted its stake in HCA Healthcare by 0.7% during the 4th quarter. Capital World Investors now owns 2,928,452 shares of the company's stock valued at $878,975,000 after acquiring an additional 19,121 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at $840,286,000. Institutional investors own 62.73% of the company's stock.

Insider Activity

In other news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the transaction, the chief operating officer now owns 12,646 shares of the company's stock, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Trading Down 0.3%

Shares of HCA stock traded down $1.06 during mid-day trading on Wednesday, hitting $384.99. 294,846 shares of the company's stock were exchanged, compared to its average volume of 1,430,549. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The stock has a 50-day simple moving average of $343.61 and a two-hundred day simple moving average of $328.91. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The stock has a market cap of $92.62 billion, a price-to-earnings ratio of 17.51, a PEG ratio of 1.10 and a beta of 1.46.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping the consensus estimate of $5.75 by $0.70. The business had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The business's quarterly revenue was up 5.7% on a year-over-year basis. During the same period last year, the company posted $5.36 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.75%. The ex-dividend date of this dividend is Monday, June 16th. HCA Healthcare's dividend payout ratio (DPR) is currently 12.81%.

Analysts Set New Price Targets

HCA has been the subject of a number of recent analyst reports. StockNews.com raised HCA Healthcare from a "hold" rating to a "buy" rating in a report on Monday, April 28th. Bank of America lowered their price objective on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research report on Monday, January 27th. Barclays reduced their price target on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a research note on Monday, January 27th. Royal Bank of Canada cut their target price on HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Finally, Guggenheim assumed coverage on HCA Healthcare in a report on Wednesday, April 9th. They set a "neutral" rating on the stock. One analyst has rated the stock with a sell rating, six have given a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $381.13.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.